What has positron emission tomography told us about the epileptogenic zone?

Hammers, A

Hammers, A.

Affiliation

Hammers A; MRC Clinical Sciences Centre, Imperial College London, South Kensington, Hammersmith Hospital, United Kingdom. alexander.hammers@imperial.ac.uk

Rev Neurol (Paris) ; 165(10): 739-41, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19740500

ABSTRACT

ABSTRACT

There is no one ligand for visualising "the epileptogenic zone". Several PET ligands, however, can help by noninvasively or minimally invasively refining hypotheses regarding its location. Their relative merits depend not only on local availability and expertise, but also on epilepsy syndrome and overall diagnostic category. FDG, flumazenil (FMZ), alpha-methyl-tryptophan (AMT), the 5-HT1A ligands, and diprenorphine are discussed.

Subject(s)

Epilepsy/diagnostic imaging; Epilepsy/physiopathology; Positron-Emission Tomography; Anticonvulsants/therapeutic use; Brain Chemistry/drug effects; Brain Chemistry/physiology; Epilepsy/drug therapy; Glucose/metabolism; Humans; Ligands; Receptors, Drug/drug effects; Seizures/diagnostic imaging; Seizures/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Positron-Emission Tomography / Epilepsy Limits: Humans Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Positron-Emission Tomography / Epilepsy Limits: Humans Language: En Year: 2009 Type: Article